FDA May Take Action Against Johnson & Johnson
Posted on June 1st, 2010 by Oddo & Babat, P.C.
The New York Times (5/28, B1, Singer) reports that McNeil Consumer Healthcare, the division of Johnson & Johnson that recalled millions of bottles of liquid children’s Tylenol, “may face criminal penalties, product seizures, or other sanctions, an official from the Food and Drug Administration said Thursday.” At a Congressional hearing yesterday, the principal deputy commissioner at the FDA, Joshua Sharfstein, said that the agency found “a pattern of violations in manufacturing and quality control practices” that “led to a number of recent recalls.”
Following revelations at the hearing that McNeil hired contractors to buy the products under orders not to mention the word ‘recall,’ the chairwomen of Johnson & Johnson’s consumer division, Colleen Goggins, apologized “to the mothers and fathers and caregivers for the concern and inconvenience” caused by the recall. Los Angeles Times (5/28, Zajac)
I consulted with David the first time a couple of years ago on a serious matter that affected a very close member of my family. Not expecting a good experience from this serious situation coupled with an attorney consultation, the entire thing surprised me as it was pleasant, professional, and completely successful. We found him clear, direct, generous and extremely knowledgeable throughout the process. I give my very strongest recommendation
